Novo CEO pressed by Senate to cut charges of obesity, diabetes medication CEO Lars Fruergaard Jørgensen told lawmakers the corporation would think about new talks with insurers with regard to the listing price ranges of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. https://busch-light-peach-calorie94948.imblogs.net/80427600/about-healthcare-news